Animal Models of Atherosclerosis-Supportive Notes and Tricks of the Trade

Anton Gisterå1, Daniel F J Ketelhuth1,2, Stephen G Malin1

  • 1Cardiovascular Medicine, Department of Medicine Solna, Karolinska Institutet and Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden (A.G., D.F.J.K., S.G.M., G.K.H.).

Insights

This review examines animal models for atherosclerosis, a major cause of death. Understanding immune-vascular interactions in these models is crucial for developing future cardiovascular disease treatments.

Area of Science:

  • Cardiovascular Research
  • Immunology
  • Animal Modeling

Background:

  • Atherosclerotic cardiovascular disease is a leading global cause of mortality.
  • Cholesterol and inflammation are key drivers of atherosclerosis, with apolipoprotein B lipoproteins triggering vascular inflammation.
  • Current treatments lack specificity for vascular inflammation, necessitating further in vivo research.

Purpose of the Study:

  • To provide a contemporary understanding of vascular disease models by integrating existing knowledge with recent findings.
  • To critically evaluate the advantages and disadvantages of various animal models used in atherosclerosis research.
  • To discuss the intricate relationship between cholesterol metabolism, immune responses, and vascular system adaptations.

Main Methods:

  • Review and synthesis of existing literature on atherosclerosis models.
  • Comparative analysis of different animal models, highlighting their strengths and weaknesses.
  • Discussion of the interplay between key biological processes in disease development.

Main Results:

  • Identification of limitations in current atherosclerosis models.
  • Emphasis on the complex interactions between cholesterol, immunity, and the vasculature.
  • Highlighting the need for improved and diverse experimental approaches.

Conclusions:

  • Current animal models have limitations that may hinder progress in understanding atherosclerosis.
  • Developing and utilizing improved or novel models is essential for advancing cardiovascular disease research.
  • Enhanced models could accelerate the development of future diagnostics and therapeutics for cardiovascular diseases.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
44
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
49
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
70
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
99
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
41